Home › Funds › TWO SIGMA ADVISERS, LP › REGN

TWO SIGMA ADVISERS, LP position in REGN

REGENERON PHARMACEUTICALS · Health Care

TWO SIGMA ADVISERS, LP reported holding 604,540 shares of REGN (REGENERON PHARMACEUTICALS) in its Q4 2025 13F filing — a position valued at US$466.6M, representing 0.91% of its reported portfolio and ranking #22 among its reported holdings. TWO SIGMA ADVISERS, LP has disclosed REGN holdings in 8 of the last 10 reported quarters, going back to Q3 2023.

Latest position (Q4 2025)604.54K sh
Reported value held$466.63M
Portfolio Weight0.91%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How TWO SIGMA ADVISERS, LP's REGN position evolved

TWO SIGMA ADVISERS, LP first disclosed a stake in REGN in Q3 2023 at 242,900 shares (US$199.9M). The position peaked in Q3 2025 at 926,200 shares, worth US$520.8M. Across 8 filings, TWO SIGMA ADVISERS, LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q4 2025) shows 604,540 shares valued at US$466.6M — a reduction of -321,660 shares quarter over quarter.. Notable position changes include a 95% trim in Q4 2023 (shares rose 10% over the following quarter), a 69% increase in Q2 2025 (shares rose 8% over the following quarter), a 35% trim in Q4 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 242.90K $199.90M New
Q4 2023 12.90K $11.33M Reduce
Q2 2024 1.00K $1.05M New
Q3 2024 900 $946.12K Reduce
Q1 2025 553.80K $351.24M New
Q2 2025 938.50K $492.71M Add
Q3 2025 926.20K $520.77M Reduce
Q4 2025 604.54K $466.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has TWO SIGMA ADVISERS, LP held REGN?

TWO SIGMA ADVISERS, LP has disclosed REGN holdings in 8 of the last 10 reported quarters, going back to Q3 2023.

What is TWO SIGMA ADVISERS, LP's current position in REGN?

As of Q4 2025, TWO SIGMA ADVISERS, LP holds 604.54K shares of REGN (REGENERON PHARMACEUTICALS), valued at $466.63M, representing 0.91% of its reported portfolio and ranking #22.

Has TWO SIGMA ADVISERS, LP been buying or selling REGN?

In the latest 13F filing (Q4 2025), TWO SIGMA ADVISERS, LP reduced its position in REGN. The position peaked in Q3 2025 at 926.20K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.